Lupin is currently trading at Rs 1900.10, up by 81.20 points or 4.46% from its previous closing of Rs 1818.90 on the BSE.
The scrip opened at Rs 1814.90 and has touched a high and low of Rs 1911.55 and Rs 1795.00 respectively. So far 141203 shares were traded on the counter.
The BSE group 'A' stock of face value Rs. 2 has touched a 52 week high of Rs. 2127.00 on 06-Oct-2015 and a 52 week low of Rs. 1540.00 on 10-Feb-2015.
Last one week high and low of the scrip stood at Rs. 1911.55 and Rs. 1603.20 respectively. The current market cap of the company is Rs. 85053.97 crore.
The promoters holding in the company stood at 46.53% while Institutions and Non-Institutions held 43.56% and 9.92% respectively.
The other top gainers of group ‘A’ on the BSE were Gujarat Pipavav Port up by 2.39%, Jaiprakash Power Ventures up by 2.27% and Shree Renuka Sugars was up by 2.16%.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1670.20 |
| Dr. Reddys Lab | 1236.10 |
| Cipla | 1234.20 |
| Zydus Lifesciences | 937.95 |
| Lupin | 2327.60 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: